Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE: 500124 | ISIN: INE089A01031 | Industry: Pharmaceuticals
| Mid-range Performer

1277.6000 -3.10 (-0.24%)

NSE Dec 04, 2025 15:31 PM

25.25% Gain from 52W Low

Volume: 2.0M

Dr. Reddy's Laboratories Ltd.

24 Jan 2025

1277.60

-0.24%

Dr Reddys Labs (HOLD): NRT business to require huge marketing spend

Hold: Dr. Reddy's Laboratories Ltd.

BOB Capital Markets Ltd.

North America sales missed our estimates and reported US$ 395mn in 3QFY25 vs US$ 445mn in 2QFY25 impacted by gRevlimid

Dr. Reddy's Laborato.. has an average target of 1281.89 from 9 brokers.